Justin Holko | VP of IR |
Leonard Schleifer | Founder, President and Chief Executive Officer |
George Yancopoulos | Co-Founder, President and Chief Scientific Officer |
Marion McCourt | EVP of Commercial |
Bob Landry | Executive VP of Finance & CFO |
Chris Raymond | Piper Sandler |
Ronny Gal | Bernstein |
Geoffrey Porges | SVB Leerink |
Yaron Werber | Cowen |
Terence Flynn | Goldman Sachs |
Kennen MacKay | RBC Capital Markets |
Carter Gould | Barclays |
Brian Skorney | Baird |
Geoff Meacham | Bank of America |
Alethia Young | Cantor Fitzgerald |
Mike King | H.C. Wainwright |
Yatin Suneja | Guggenheim Partners |
Welcome to the Regeneron Pharmaceuticals Second Quarter 2021 Earnings Conference Call. My name is Tamia, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session. Please note that this conference is being recorded.